• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prevalence of Maculopathy Associated with Long-Term Pentosan Polysulfate Therapy.

作者信息

Vora Robin A, Patel Amar P, Melles Ronald

机构信息

Kaiser Permanente Northern California, Oakland, California.

Kaiser Permanente Northern California, Oakland, California.

出版信息

Ophthalmology. 2020 Jun;127(6):835-836. doi: 10.1016/j.ophtha.2020.01.017. Epub 2020 Jan 17.

DOI:10.1016/j.ophtha.2020.01.017
PMID:32085877
Abstract
摘要

相似文献

1
Prevalence of Maculopathy Associated with Long-Term Pentosan Polysulfate Therapy.与长期戊聚糖多硫酸盐治疗相关的黄斑病变患病率
Ophthalmology. 2020 Jun;127(6):835-836. doi: 10.1016/j.ophtha.2020.01.017. Epub 2020 Jan 17.
2
Pentosan Polysulfate Maculopathy: What Urologists Should Know in 2020.戊聚糖多硫酸酯斑病变：2020 年泌尿科医生应该了解的知识。
Urology. 2021 Jan;147:109-118. doi: 10.1016/j.urology.2020.08.072. Epub 2020 Oct 10.
3
Ocular Toxicity Associated With Pentosan Polysulfate Sodium.
Mayo Clin Proc. 2021 Jun;96(6):1682-1684. doi: 10.1016/j.mayocp.2021.04.002.
4
Maculopathy caused by pentosan polysulfate.戊聚糖多硫酸盐引起的黄斑病变。
CMAJ. 2021 May 3;193(18):E645. doi: 10.1503/cmaj.201900.
5
Pentosan Polysulfate-Associated Macular Disease in Patients With Interstitial Cystitis.间质性膀胱炎患者的聚戊糖多硫酸钠相关性黄斑病变。
Obstet Gynecol. 2020 May;135(5):1091-1094. doi: 10.1097/AOG.0000000000003794.
6
Strength of Association between Pentosan Polysulfate and a Novel Maculopathy.戊聚糖多硫酸酯与一种新型黄斑病变之间的关联强度
Ophthalmology. 2019 Oct;126(10):1464-1466. doi: 10.1016/j.ophtha.2019.04.024. Epub 2019 Apr 18.
7
Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis.五碳糖相关的黄斑病变：基于前瞻性多模态分析的患病率、筛查指南和病变特征。
Can J Ophthalmol. 2020 Apr;55(2):116-125. doi: 10.1016/j.jcjo.2019.12.001. Epub 2020 Jan 20.
8
Age-Related Macular Degeneration Masquerade: A Review of Pentosan Polysulfate Maculopathy and Implications for Clinical Practice.年龄相关性黄斑变性伪装：戊聚糖多硫酸酯黄斑病变的综述及对临床实践的影响。
Asia Pac J Ophthalmol (Phila). 2022;11(2):100-110. doi: 10.1097/APO.0000000000000504.
9
Pentosan Polysulfate Sodium Exposure and Drug-Induced Maculopathy in Commercially Insured Patients in the United States.戊聚糖多硫酸钠暴露与美国商业保险患者的药物诱导性黄斑病变。
Ophthalmology. 2020 Apr;127(4):535-543. doi: 10.1016/j.ophtha.2019.10.036. Epub 2019 Nov 5.
10
Pentosan polysulfate maculopathy versus age-related macular degeneration: comparative assessment with multimodal imaging.聚硫酸戊聚糖黄斑病变与年龄相关性黄斑变性：多模态成像的比较评估
Can J Ophthalmol. 2022 Feb;57(1):16-22. doi: 10.1016/j.jcjo.2021.02.007. Epub 2021 Mar 12.

引用本文的文献

1
Evaluating for pentosan polysulfate maculopathy at a single academic institution.在单一学术机构评估戊聚糖多硫酸酯黄斑病变。
Ther Adv Ophthalmol. 2025 Aug 11;17:25158414251364944. doi: 10.1177/25158414251364944. eCollection 2025 Jan-Dec.
2
2025 Canadian Urological Association Guideline: Selected treatment recommendations for interstitial cystitis/bladder pain syndrome.《2025年加拿大泌尿外科协会指南：间质性膀胱炎/膀胱疼痛综合征的选定治疗建议》
Can Urol Assoc J. 2025 Apr;19(4):90-103. doi: 10.5489/cuaj.9182.
3
Retrospective study of incidence/prevalence of pigmentary maculopathy and retinopathy in patients receiving pentosan polysulfate sodium.
接受聚多卡醇硫酸酯钠治疗的患者色素性黄斑病变和视网膜病变发病率/患病率的回顾性研究。
PLoS One. 2025 Jan 9;20(1):e0313497. doi: 10.1371/journal.pone.0313497. eCollection 2025.
4
Systemic Medications and Their Ocular Side Effects.全身用药及其眼部副作用。
Cureus. 2024 Dec 2;16(12):e74976. doi: 10.7759/cureus.74976. eCollection 2024 Dec.
5
Advanced pentosan polysulfate sodium maculopathy with low cumulative exposure and hydroxychloroquine use.低累积暴露量及使用羟氯喹导致的晚期戊聚糖多硫酸酯钠黄斑病变
Am J Ophthalmol Case Rep. 2024 Nov 22;36:102224. doi: 10.1016/j.ajoc.2024.102224. eCollection 2024 Dec.
6
Mimickers of hydroxychloroquine retinal toxicity.羟氯喹视网膜毒性的模仿者。
Clin Exp Ophthalmol. 2024 Dec;52(9):1003-1015. doi: 10.1111/ceo.14461. Epub 2024 Dec 3.
7
Update on Retinal Drug Safety: Proceedings of the ASRS ReST Committee Webinar Part 1.视网膜药物安全性最新进展：美国视网膜专家协会视网膜药物安全委员会网络研讨会第1部分会议记录
J Vitreoretin Dis. 2024 Aug 22;8(5):500-507. doi: 10.1177/24741264241261441. eCollection 2024 Sep-Oct.
8
Real-World Practices of Pentosan Polysulfate Maculopathy Screening in Various Clinical Settings and Practice-Associated Factors.戊聚糖多硫酸酯黄斑病变在不同临床环境中的真实世界筛查实践及与实践相关的因素
J Clin Med. 2024 Aug 27;13(17):5090. doi: 10.3390/jcm13175090.
9
Pentosan Polysulfate Maculopathy With 13 Years of Follow-up Imaging.随访13年的聚硫酸戊聚糖黄斑病变影像学表现
J Vitreoretin Dis. 2024 Jan 31;8(3):325-333. doi: 10.1177/24741264241228375. eCollection 2024 May-Jun.
10
Screening practices and risk assessment for maculopathy in pentosan polysulfate users across different exposure levels.不同暴露水平下戊聚糖多硫酸酯使用者的黄斑病变筛查实践和风险评估。
Sci Rep. 2024 May 17;14(1):11270. doi: 10.1038/s41598-024-62041-y.